ireland approv icn ribavirin treat hiv icn pharmaceut inc announc friday irish govern approv sale firm controversi drug ribavirin peopl infect viru caus aid mark first time nation done costa mesa base pharmaceut compani said republ ireland allow sale ribavirin treat peopl infect human immunodefici viru hiv caus aid peopl suffer hiv symptom fever night sweat fatigu would elig receiv antivir drug world health organ estim 140 peopl contract full case acquir immun defici syndrom ireland nearli 1 000 peopl infect hiv u food drug administr refus approv ribavirin treat hiv infect patient deni icn request distribut drug pend approv drug wide market icn cure sever maladi view skeptic scientif circl treatment aid relat ill icn announc march given tri win fda approv ribavirin treat hiv patient even though compani consid drug effect purpos ribavirin fda approv use treat sever lower respiratori tract infect young children icn spokesman jack sholl said compani plan present time revers posit seek fda approv barbara jone ireland vice consul san francisco said countri minist health grant icn limit licens sell ribavirin mean avail doctor expertis aid treatment gener practition promot drug jone said said irish doctor gener advoc earli intervent strategi receiv unrestrict licens walk pharmaci get willi nilli sholl said anticip sever countri follow ireland lead compani ask canada spain among other review ribavirin treat hiv icn stock shot 76 sinc june 7 close friday 4 625 per share 50 cent stock trade rumor specul year whether drug ever approv aid use said ken bohring analyst new york brokerag prudenti bach secur wall street analyst said ribavirin must still pass mani clinic trial gain greater accept treat hiv first step get wildli enthusiast bohring said viren mehta research new york base pharmaceut research firm mehta amp isali said think mani convinc clinic trial done show variou health offici major market real benefit ireland base approv two controversi studi conduct 1986 first studi show 10 56 peopl infect hiv given placebo advanc full case aid within 24 week six 107 hiv carrier treat ribavirin becam serious ill methodolog blast scientist includ fda call result meaningless research determin particip aid patient stage diseas dr peter heseltin associ chairman medicin usc one investig 1986 studi said think ribavirin could help delay onset aid new studi need see compar wide accept anti aid drug azidothymidin azt